KPC Pharmaceuticals,Inc. (SHA:600422)

KPC Pharmaceuticals,Inc. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Cash & Equivalents	1,255	2,271	1,500	1,658	1,574	1,485
Trading Asset Securities	1,827	471.28	603.8	319.4	160.5	334.76
Cash & Short-Term Investments	3,082	2,742	2,103	1,978	1,735	1,820
Cash Growth	38.32%	30.36%	6.35%	14.01%	-4.68%	22.80%
Accounts Receivable	3,591	3,855	3,225	2,625	2,011	1,551
Other Receivables	239.67	123.73	797.75	95.1	169.09	150.59
Receivables	3,830	3,979	4,022	2,720	2,180	1,702
Inventory	1,464	1,540	1,772	1,681	1,884	1,718
Other Current Assets	259.05	294.82	250.14	388.21	381.96	320.86
Total Current Assets	8,635	8,555	8,148	6,766	6,180	5,560
Property, Plant & Equipment	1,249	1,286	1,307	1,291	1,361	1,428
Long-Term Investments	293.43	305.46	319.61	320.61	278.24	241.55
Goodwill	1,503	1,503	1,503	91.73	91.73	91.73
Other Intangible Assets	387	412.22	441.97	355.98	408.88	369.04
Long-Term Deferred Tax Assets	286.27	258.28	269.12	245.6	233.83	236.74
Long-Term Deferred Charges	253.29	237.84	237	199.07	274.49	247.86
Other Long-Term Assets	50.24	53.12	69.83	161.17	64.98	37.13
Total Assets	12,658	12,611	12,295	9,432	8,893	8,213
Accounts Payable	808.25	1,056	936.78	977.12	1,239	821.45
Accrued Expenses	1,618	1,831	1,597	1,262	1,117	1,137
Short-Term Debt	826.31	658.04	725.49	912.76	641.75	627.81
Current Portion of Long-Term Debt	125.95	61.05	1	99.5	0.2	0.2
Current Portion of Leases	22.31	19.28	22.46	22.57	36.07	22.43
Current Income Taxes Payable	141.44	158.94	149.75	78.76	93.28	78.8
Current Unearned Revenue	81.34	83.32	102.63	186.37	74.09	82.3
Other Current Liabilities	1,238	1,624	329.7	350.01	284.76	379.43
Total Current Liabilities	4,862	5,491	3,865	3,889	3,485	3,149
Long-Term Debt	697.06	46.05	107.56	60	99.5	99.7
Long-Term Leases	46.81	48.59	44.24	44.77	50.47	68.1
Long-Term Unearned Revenue	234.65	229.92	224.09	207.58	245.34	273.58
Long-Term Deferred Tax Liabilities	20.41	21.65	24.28	10.64	15.42	18.39
Other Long-Term Liabilities	25.92	28.03	75.97	77.58	56.67	1.05
Total Liabilities	5,887	5,865	4,341	4,289	3,953	3,610
Common Stock	756.98	756.98	757.99	758.26	758.26	758.26
Additional Paid-In Capital	520.62	520.62	2,327	1,161	1,169	1,163
Retained Earnings	3,953	3,981	3,490	3,071	2,894	2,561
Treasury Stock	-	-	-10.42	-13.15	-26.3	-26.3
Comprehensive Income & Other	-3.25	-5.29	-1.62	6.3	-11.5	-4.93
Total Common Equity	5,227	5,254	6,562	4,983	4,783	4,451
Minority Interest	1,544	1,493	1,392	159.5	156.98	152
Shareholders' Equity	6,771	6,746	7,954	5,143	4,940	4,603
Total Liabilities & Equity	12,658	12,611	12,295	9,432	8,893	8,213
Total Debt	1,718	833.02	900.74	1,140	828	818.24
Net Cash (Debt)	1,363	1,909	1,203	838.19	906.76	1,002
Net Cash Growth	2.64%	58.73%	43.47%	-7.56%	-9.49%	14.42%
Net Cash Per Share	1.80	2.53	1.58	1.12	1.20	1.32
Filing Date Shares Outstanding	756.98	756.98	757.11	758.13	758.26	758.26
Total Common Shares Outstanding	756.98	756.98	757.99	758.26	758.26	758.26
Working Capital	3,773	3,064	4,283	2,878	2,695	2,411
Book Value Per Share	6.91	6.94	8.66	6.57	6.31	5.87
Tangible Book Value	3,337	3,338	4,617	4,535	4,283	3,990
Tangible Book Value Per Share	4.41	4.41	6.09	5.98	5.65	5.26
Buildings	1,326	1,325	1,262	1,137	1,136	1,155
Machinery	1,048	1,058	1,011	988.66	980.07	884.96
Construction In Progress	86.18	76.46	100.51	64.65	43.51	75.69

Source: S&P Global Market Intelligence. Standard template. Financial Sources.